Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates.

Gallagher, Molly E; Sieben, Andrew J; Nelson, Kristin N; Kraay, Alicia N M; Orenstein, Walter A; Lopman, Ben; Handel, Andreas; Koelle, Katia

Gallagher, Molly E; Sieben, Andrew J; Nelson, Kristin N; Kraay, Alicia N M; Orenstein, Walter A; Lopman, Ben; Handel, Andreas; Koelle, Katia.

Gallagher ME; Department of Biology, Emory University, Atlanta, GA, USA. mgallagher@emory.edu.
Sieben AJ; School of Medicine, Emory University, Atlanta, GA, USA.
Nelson KN; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Kraay ANM; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Orenstein WA; Emory Vaccine Center, School of Medicine, Emory University, Atlanta, GA, USA.
Lopman B; Emory-UGA Center of Excellence of Influenza Research and Surveillance, Atlanta, GA, USA.
Handel A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Koelle K; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, USA.

Nat Med ; 27(1): 4-5, 2021 01.

Article in English | MEDLINE | ID: covidwho-1065911

Subject(s)

COVID-19 Vaccines/administration & dosage; COVID-19/prevention & control; SARS-CoV-2/physiology; Biomedical Research; COVID-19/economics; COVID-19/virology; COVID-19 Vaccines/adverse effects; Humans; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-020-01172-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google